tenofovir has been researched along with Diabetes Mellitus in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 6 (54.55) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, HL; Hui, VW; Lai, JC; Lai, MS; Liang, LY; Tse, YK; Wong, GL; Wong, VW; Yip, TC | 1 |
| Gill, S; Kalinoski, T; Mehboob, G; Mpejane, O; Zilwa, N | 1 |
| Goffard, JC; Henrard, S; Noure, L; Simeni Njonnou, SR | 1 |
| Hill, A; Shah, S | 2 |
| Daugherty, T; Goel, A; Kim, WR; Kwo, PY; Kwong, A; Mannalithara, A; Sripongpun, P | 1 |
| Andrinopoulou, ER; Bakker, JA; Bierau, J; Leers, MPG; Lowe, SH; Paulussen, ADC; Peltenburg, NC; Schippers, JA; van den Bosch, BJC; Verbon, A | 1 |
| Aguilar, A; De La Torre, J; Del Arco, A; García-Alegría, J; Olalla, J; Pombo, M; Prada, JL; Ruiz-Mateas, F; Urdiales, D | 1 |
| Aiestarán, A; Bonet, J; Bonjoch, A; Clotet, B; Echeverría, P; Juega, J; Negredo, E; Pérez, V; Pérez-Alvarez, N; Puig, J; Romero, R | 1 |
| Battegay, M; Burkhalter, F; Dickenmann, M; Elzi, L; Hopfer, H; Kurz, M; Mayr, M | 1 |
| Chang, KC; Chen, CH; Hu, TH; Hung, CH; Kee, KM; Lee, CM; Lu, SN; Tseng, PL; Wang, HM; Wang, JH; Yen, YH | 1 |
2 review(s) available for tenofovir and Diabetes Mellitus
| Article | Year |
|---|---|
Risks of metabolic syndrome and diabetes with integrase inhibitor-based therapy.
Topics: Alanine; Anti-HIV Agents; Diabetes Mellitus; HIV Infections; HIV Integrase Inhibitors; Humans; Metabolic Syndrome; Tenofovir; Weight Gain | 2021 |
Risks of metabolic syndrome and diabetes with integrase inhibitor-based therapy: Republication.
Topics: Diabetes Mellitus; HIV Infections; HIV Integrase Inhibitors; Humans; Metabolic Syndrome; Tenofovir | 2021 |
9 other study(ies) available for tenofovir and Diabetes Mellitus
| Article | Year |
|---|---|
Diabetes Mellitus Impacts on the Performance of Hepatocellular Carcinoma Risk Scores in Chronic Hepatitis B Patients.
Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Diabetes Mellitus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Risk Factors; Tenofovir | 2023 |
Fanconi syndrome, diabetes insipidus, and acute kidney injury due to tenofovir disoproxil fumarate: A case report.
Topics: Acute Kidney Injury; Adenine; Anti-HIV Agents; Diabetes Insipidus; Diabetes Mellitus; Fanconi Syndrome; Female; HIV Infections; Humans; Middle Aged; Protease Inhibitors; Tenofovir | 2023 |
Severe rhabdomyolysis and acute asymptomatic pancreatitis following the concomitant use of Biktarvy in the setting of hyperosmolar diabetic crisis.
Topics: Adenine; Alanine; Anti-HIV Agents; Cholangiopancreatography, Magnetic Resonance; Diabetes Mellitus; Drug Combinations; Emtricitabine; Heterocyclic Compounds, 4 or More Rings; HIV Infections; Humans; Insulin; Male; Middle Aged; Pancreatitis; Piperazines; Pyridones; Rhabdomyolysis; Tenofovir | 2020 |
Tenofovir Alafenamide Attenuates Effects of Diabetes and Body Mass on Serum Alanine Aminotransferase Activities in Patients With Chronic Hepatitis B.
Topics: Alanine; Alanine Transaminase; Antiviral Agents; Diabetes Mellitus; Hepatitis B, Chronic; Humans; Tenofovir | 2022 |
Metabolic events in HIV-infected patients using abacavir are associated with erythrocyte inosine triphosphatase activity.
Topics: Adult; Aged; Diabetes Mellitus; Didanosine; Dideoxynucleosides; Erythrocytes; Female; Genotype; HIV Infections; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Pyrophosphatases; Reverse Transcriptase Inhibitors; Tenofovir | 2019 |
Left ventricular hypertrophy detected by echocardiography in HIV-infected patients.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Carbamates; Comorbidity; Cross-Sectional Studies; Cyclopropanes; Diabetes Mellitus; Drug Combinations; Dyslipidemias; Echocardiography; Female; Furans; HIV Infections; Humans; Hypertension; Hypertrophy, Left Ventricular; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Organophosphates; Organophosphonates; Risk Factors; Ritonavir; Smoking; Spain; Sulfonamides; Tenofovir; Zidovudine | 2013 |
High prevalence of signs of renal damage despite normal renal function in a cohort of HIV-infected patients: evaluation of associated factors.
Topics: Adenine; Adult; Age Factors; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Cross-Sectional Studies; Diabetes Mellitus; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Prevalence; Prospective Studies; Risk Factors; Socioeconomic Factors; Spain; Surveys and Questionnaires; Tenofovir; Viral Load | 2014 |
Acute kidney injury KDIGO stage 2 to 3 in HIV-positive patients treated with cART--a case series over 11 years in a cohort of 1,153 patients.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Retroviral Agents; Arteriosclerosis; Diabetes Mellitus; Drug Therapy, Combination; Female; Glomerular Filtration Rate; HIV Infections; Humans; Hypertension; Incidence; Male; Middle Aged; Renal Dialysis; Severity of Illness Index; Tenofovir | 2015 |
Three-year efficacy and safety of tenofovir in nucleos(t)ide analog-naïve and nucleos(t)ide analog-experienced chronic hepatitis B patients.
Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Comorbidity; Diabetes Mellitus; Female; Glomerular Filtration Rate; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Nucleosides; Nucleotides; Retrospective Studies; Tenofovir; Time Factors; Treatment Outcome | 2016 |